Sygnis AG (LIO1) - Medical Equipment - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products include single cell WGA kits, WGA kits, RCA kit, one step RT-PCR kit and one step RT-qPCR kit, among others. Sygnis offers products such as single cell reverse transcriptase RNaseH+ and RNaseH-, among others. The companys single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. The company has presence in Germany and Spain. Sygnis is headquartered in Heidelberg, Germany.
Sygnis AG (LIO1) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products include single cell WGA kits, WGA kits, RCA kit, one step RT-PCR kit and one step RT-qPCR kit, among others. Sygnis offers products such as single cell reverse transcriptase RNaseH+ and RNaseH-, among others. The companys single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. The company has presence in Germany and Spain. Sygnis is headquartered in Heidelberg, Germany.
Sygnis AG (LIO1) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 4
List of Figures 5
Sygnis AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sygnis AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sygnis AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sygnis AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sygnis AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sygnis AG, Medical Equipment, Deal Details 11
Partnerships 11
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 11
Sygnis Enters into Agreement with TANON 12
Sygnis Enters into Distribution Agreement with Philekorea Technology, Pharm Tech Korea and Axil Scientific 13
SYGNIS Enters into Distribution Agreement with Lucigen 14
BioCat Enters into Distribution Agreement with Sygnis 14
Mologic Enters into Licensing Agreement with Innova Biosciences 15
Equity Offering 16
Sygnis Raises USD6 Million in Private Placement of Shares 16
Sygnis Raises USD5.4 Million in Rights Offering of Shares 17
Acquisition 18
Sygnis Acquires Innova Biosciences from Innova Partnerships 18
Sygnis AG - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 11, 2017: SYGNIS reports financial results for first quarter of 2017 23
Nov 09, 2016: SYGNIS Reports Nine Month Results for the Period Ended September 30, 2016 25
Aug 03, 2016: SYGNIS reports half-year results for the period ended 30 June 2016 27
May 12, 2016: SYGNIS reports results for the first quarter 2016 28
Apr 28, 2016: SYGNIS reports financial results for fiscal year 2015 29
Corporate Communications 31
Jun 06, 2017: SYGNIS announces Management and Supervisory Board changes 31
Mar 01, 2017: SYGNIS announces management changes 32
Aug 08, 2016: SYGNIS Strengthens Management Team with Appointment of Dr. Heikki Lanckriet 33
Product News 34
Oct 04, 2016: SYGNIS Presents Innovative Technologies in Molecular Biology at Two Renowned Scientific Conferences 34
Jul 11, 2016: SYGNIS announces global launch of TruePrime Single Cell WGA Kit V2 35
Jan 13, 2016: SYGNIS Announces Global Launch of SunScript One Step RT-qPCR Kit 36
Other Significant Developments 37
Mar 07, 2017: SYGNIS launches TrueAdvance amplification service to address quality needs in next-generation sequencing 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List Of Tables
Sygnis AG, Medical Equipment, Key Facts, 2016 1
Sygnis AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Sygnis AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sygnis AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sygnis AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sygnis AG, Deals By Market, 2011 to YTD 2017 9
Sygnis AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 11
Sygnis Enters into Agreement with TANON 12
Sygnis Enters into Distribution Agreement with Philekorea Technology, Pharm Tech Korea and Axil Scientific 13
SYGNIS Enters into Distribution Agreement with Lucigen 14
BioCat Enters into Distribution Agreement with Sygnis 14
Mologic Enters into Licensing Agreement with Innova Biosciences 15
Sygnis Raises USD6 Million in Private Placement of Shares 16
Sygnis Raises USD5.4 Million in Rights Offering of Shares 17
Sygnis Acquires Innova Biosciences from Innova Partnerships 18
Sygnis AG, Key Competitors 20
Sygnis AG, Key Employees 21
Sygnis AG, Other Locations 22
Sygnis AG, Subsidiaries 22
List Of Figures
Sygnis AG, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Sygnis AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Sygnis AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Sygnis AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Sygnis AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sygnis AG, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Sygnis AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sygnis AG, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
RELATED REPORTS
4basebio AG (LIO1) - Financial and Strategic SWOT Analysis Review
4basebio AG( 4basebio) formerly Expedeon AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
